(MedPage Today) — A higher and less frequent dose of aflibercept (Eylea) was noninferior to the standard dose for the treatment of polypoidal choroidal vasculopathy (PCV) in patients with neovascular (“wet”) age-related macular degeneration (AMD…
Understanding the potential of CAR-T therapy in autoimmune disease treatment
Originally developed for aggressive blood cancers, CAR-T cell therapy is now being explored as a possible breakthrough treatment for autoimmune...






